Very good experience
February 25, 2026

Very good experience

Anonymous | TrustRadius Reviewer
Score 7 out of 10
Vetted Review
Verified User

Overall Satisfaction with PitchBook

In my work activities I perform venture capital analysis, deal sourcing, and evaluation of early-stage technology companies. I use PitchBook to reviewed investment-related materials including market sizing analyses, business cases, and venture-style diligence documents across life sciences and deep tech. I use PitchBook to make competitive landscape analysis, comparable benchmark searches, firm evaluations for M&A purposes

Pros

  • Providing insight of companies key financial books
  • Providing a summary of deals
  • Estimate KPIs

Cons

  • Comparable companies
  • Insights on detailed achievements of companies (i.e. clinical trials for pharma/biotech companies)
  • Update key information more often
  • Time saving
  • Simplicity
  • Reliability of data
My organization hasked for help to customer service and reported a very good experience
My organization utilize PitchBook both in the target search and in the post-closing monitoring phase.In the deal search PitchBook is asked to provide info on the target's competitive environment, financial books, capitaliations, and success rate. IN the monitoring phase we conduct impairment test of the partecipated company, portfolio risk analysis, support in the partnership building
the rating refletcs the balance between pros and cons we encoutered

Do you think PitchBook delivers good value for the price?

Yes

Are you happy with PitchBook's feature set?

Yes

Did PitchBook live up to sales and marketing promises?

Yes

Did implementation of PitchBook go as expected?

Yes

Would you buy PitchBook again?

Yes

PitchBook is well suited for P/E, Banks, M&A in broad business areas. PitchBook is less appropriate for the fields like pharma/biotech/medtech where the buseinss is strictly linked to regulatory authorities and the fierm value is affected by clinical centers activation, patient enrollment, clicnical endopoint achievement , dossier approval (EMA/FDA)

PitchBook Feature Ratings

Public Company Data
8
Private Company Data
6
Industry and Sector Research
6
Industry-Specific Information
5
Independent Research Access
5
M&A Analysis
8
Supply Chain Data
Not Rated
ESG Data
Not Rated
Credit Ratings Reports
Not Rated
Macroeconomic News
Not Rated
Search Tools
Not Rated

Comments

More Reviews of PitchBook